Cyclodextrin nanoparticles in targeted cancer theranostics

The field of cancer nanotheranostics is rapidly evolving, with cyclodextrin (CD)-based nanoparticles emerging as a promising tool. CDs, serving as nanocarriers, have higher adaptability and demonstrate immense potential in delivering powerful anti-cancer drugs, leading to promising and specific ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Roshnee, Jayawant, Maharsh, Raut, Rajesh, Lakkakula, Jaya, Roy, Arpita, Alghamdi, Saad, Qusty, Naeem F., Sharma, Rohit, Verma, Devvret, Khandaker, Mayeen Uddin, Almujally, Abdullah, Tamam, Nissren, Sulieman, Abdelmoneim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434568/
https://www.ncbi.nlm.nih.gov/pubmed/37601050
http://dx.doi.org/10.3389/fphar.2023.1218867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434568/
https://www.ncbi.nlm.nih.gov/pubmed/37601050
http://dx.doi.org/10.3389/fphar.2023.1218867

Ejemplares similares